{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T15:51:33Z","timestamp":1791906693431,"version":"4.3.4"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008903","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["MOHW109-TDU-B-211-134009"],"award-info":[{"award-number":["MOHW109-TDU-B-211-134009"]}],"id":[{"id":"10.13039\/100008903","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 109-2314-B-002-221"],"award-info":[{"award-number":["MOST 109-2314-B-002-221"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["109-2314-B-002-222"],"award-info":[{"award-number":["109-2314-B-002-222"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["111-2314-B-002-280"],"award-info":[{"award-number":["111-2314-B-002-280"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Neoplasia"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bneo.2026.100286","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T16:29:00Z","timestamp":1786638540000},"page":"100286","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic implications of TET2 variant allele frequency in chronic myelomonocytic leukemia: a multicenter study"],"prefix":"10.1016","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4483-5627","authenticated-orcid":false,"given":"Yu-Hung","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3565-2709","authenticated-orcid":false,"given":"Doroth\u00e9e","family":"Selimoglu-Buet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6829-5544","authenticated-orcid":false,"given":"Carmelo","family":"Gurnari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew T.","family":"Villaume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1754-1204","authenticated-orcid":false,"given":"Somedeb","family":"Ball","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6099-5324","authenticated-orcid":false,"given":"Nathalie","family":"Droin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussein","family":"Awada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Jerez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrius","family":"Zucenka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5052-9445","authenticated-orcid":false,"given":"Chi-Yuan","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7160-2285","authenticated-orcid":false,"given":"Chien-Chin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2780-4845","authenticated-orcid":false,"given":"Hsin-An","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2967-698X","authenticated-orcid":false,"given":"Wen-Chien","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hwei-Fang","family":"Tien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaroslaw P.","family":"Maciejewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Savona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8629-1341","authenticated-orcid":false,"given":"Eric","family":"Solary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3494-0979","authenticated-orcid":false,"given":"Kiran","family":"Batta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0715-1402","authenticated-orcid":false,"given":"Daniel H.","family":"Wiseman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.bneo.2026.100286_bib1","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1002\/ajh.27271","article-title":"Chronic myelomonocytic leukemia: 2024 update on diagnosis, risk stratification and management","volume":"99","author":"Patnaik","year":"2024","journal-title":"Am J Hematol"},{"issue":"7","key":"10.1016\/j.bneo.2026.100286_bib2","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"issue":"7","key":"10.1016\/j.bneo.2026.100286_bib3","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2015.53","article-title":"An international data set for CMML validates prognostic scoring systems and demonstrates a need for novel prognostication strategies","volume":"5","author":"Padron","year":"2015","journal-title":"Blood Cancer J"},{"issue":"19","key":"10.1016\/j.bneo.2026.100286_bib4","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1200\/JCO.2012.47.3314","article-title":"Prognostic score including gene mutations in chronic myelomonocytic leukemia","volume":"31","author":"Itzykson","year":"2013","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.bneo.2026.100286_bib5","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1038\/leu.2014.125","article-title":"ASXL1 and SETBP1 mutations and their prognostic contribution in chronic myelomonocytic leukemia: a two-center study of 466 patients","volume":"28","author":"Patnaik","year":"2014","journal-title":"Leukemia"},{"issue":"10","key":"10.1016\/j.bneo.2026.100286_bib6","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1182\/blood-2016-05-714030","article-title":"Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia","volume":"128","author":"Elena","year":"2016","journal-title":"Blood"},{"issue":"17","key":"10.1016\/j.bneo.2026.100286_bib7","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1200\/JCO-25-02116","article-title":"Molecular-based ecosystem to improve personalized medicine in chronic myelomonocytic leukemia","volume":"44","author":"Lanino","year":"2026","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.bneo.2026.100286_bib8","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.3324\/haematol.2009.011205","article-title":"TET2 gene mutation is a frequent and adverse event in chronic myelomonocytic leukemia","volume":"94","author":"Olivier","year":"2009","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.bneo.2026.100286_bib9","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/s41375-019-0690-7","article-title":"Clinical, molecular, and prognostic correlates of number, type, and functional localization of TET2 mutations in chronic myelomonocytic leukemia (CMML)\u2014a study of 1084 patients","volume":"34","author":"Coltro","year":"2020","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.bneo.2026.100286_bib10","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/leu.2011.10","article-title":"Molecular profiling of chronic myelomonocytic leukemia reveals diverse mutations in >80% of patients with TET2 and EZH2 being of high prognostic relevance","volume":"25","author":"Grossmann","year":"2011","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.bneo.2026.100286_bib11","doi-asserted-by":"crossref","first-page":"e385","DOI":"10.1038\/bcj.2015.113","article-title":"Prognostic interaction between ASXL1 and TET2 mutations in chronic myelomonocytic leukemia","volume":"6","author":"Patnaik","year":"2016","journal-title":"Blood Cancer J"},{"issue":"9","key":"10.1016\/j.bneo.2026.100286_bib12","doi-asserted-by":"crossref","first-page":"e472","DOI":"10.1038\/bcj.2016.82","article-title":"Number and type of TET2 mutations in chronic myelomonocytic leukemia and their clinical relevance","volume":"6","author":"Patnaik","year":"2016","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.bneo.2026.100286_bib13","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ebiom.2018.04.018","article-title":"Prognostic role of gene mutations in chronic myelomonocytic leukemia patients treated with hypomethylating agents","volume":"31","author":"Duchmann","year":"2018","journal-title":"EBioMedicine"},{"issue":"10","key":"10.1016\/j.bneo.2026.100286_bib14","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.3324\/haematol.2024.285410","article-title":"ASXL1\/TET2 genotype-based risk stratification outperforms ASXL1 mutational impact and is independent of mutant variant allele fractions in chronic myelomonocytic leukemia","volume":"109","author":"Csizmar","year":"2024","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.bneo.2026.100286_bib15","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1182\/bloodadvances.2021005418","article-title":"TET2 mutations as a part of DNA dioxygenase deficiency in myelodysplastic syndromes","volume":"6","author":"Gurnari","year":"2022","journal-title":"Blood Adv"},{"issue":"6","key":"10.1016\/j.bneo.2026.100286_bib16","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1038\/s41375-023-01887-z","article-title":"Single cell proteogenomic analysis of aberrant monocytosis in TET2 mutant premalignant and malignant hematopoiesis","volume":"37","author":"Lasho","year":"2023","journal-title":"Leukemia"},{"issue":"9","key":"10.1016\/j.bneo.2026.100286_bib17","doi-asserted-by":"crossref","first-page":"e351","DOI":"10.3324\/haematol.2015.126227","article-title":"Adverse prognostic effect of homozygous TET2 mutation on the relapse risk of acute myeloid leukemia in patients of normal karyotype","volume":"100","author":"Jae-Sook","year":"2015","journal-title":"Haematologica"},{"issue":"8","key":"10.1016\/j.bneo.2026.100286_bib18","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1038\/s41375-018-0150-9","article-title":"Consequences of mutant TET2 on clonality and subclonal hierarchy","volume":"32","author":"Hirsch","year":"2018","journal-title":"Leukemia"},{"issue":"12","key":"10.1016\/j.bneo.2026.100286_bib19","first-page":"4476","article-title":"Impact of mutational variant allele frequency on prognosis in myelodysplastic syndromes","volume":"10","author":"Jiang","year":"2020","journal-title":"Am J Cancer Res"},{"issue":"2","key":"10.1016\/j.bneo.2026.100286_bib20","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/bjh.18681","article-title":"A three-gene leukaemic stem cell signature score is robustly prognostic in chronic myelomonocytic leukaemia","volume":"201","author":"Wang","year":"2023","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.bneo.2026.100286_bib21","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1182\/bloodadvances.2018024216","article-title":"Invariant phenotype and molecular association of biallelic TET2 mutant myeloid neoplasia","volume":"3","author":"Awada","year":"2019","journal-title":"Blood Adv"},{"issue":"3","key":"10.1016\/j.bneo.2026.100286_bib22","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/bjh.15408","article-title":"Transcriptomic rationale for synthetic lethality-targeting ERCC1 and CDKN1A in chronic myelomonocytic leukaemia","volume":"182","author":"Hurtado","year":"2018","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.bneo.2026.100286_bib23","doi-asserted-by":"crossref","first-page":"5455","DOI":"10.1038\/s41467-018-07801-x","article-title":"A miR-150\/TET3 pathway regulates the generation of mouse and human non-classical monocyte subset","volume":"9","author":"Selimoglu-Buet","year":"2018","journal-title":"Nat Commun"},{"issue":"9","key":"10.1016\/j.bneo.2026.100286_bib24","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1038\/leu.2016.93","article-title":"Frequent reconstitution of IDH2R140Q mutant clonal multilineage hematopoiesis following chemotherapy for acute myeloid leukemia","volume":"30","author":"Wiseman","year":"2016","journal-title":"Leukemia"},{"issue":"22","key":"10.1016\/j.bneo.2026.100286_bib25","doi-asserted-by":"crossref","first-page":"4535","DOI":"10.1182\/bloodadvances.2021005141","article-title":"A CIBERSORTx-based immune cell scoring system could independently predict the prognosis of patients with myelodysplastic syndromes","volume":"5","author":"Wang","year":"2021","journal-title":"Blood Adv"},{"issue":"12","key":"10.1016\/j.bneo.2026.100286_bib26","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1182\/blood-2014-10-607341","article-title":"An international consortium proposal of uniform response criteria for myelodysplastic\/myeloproliferative neoplasms (MDS\/MPN) in adults","volume":"125","author":"Savona","year":"2015","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.bneo.2026.100286_bib27","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1038\/s41375-022-01733-8","article-title":"Multi-hit TET2 mutations as a differential molecular signature of oligomonocytic and overt chronic myelomonocytic leukemia","volume":"36","author":"Garcia-Gisbert","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.bneo.2026.100286_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2023.107391","article-title":"TET2 somatic copy number alterations and allelic imbalances in chronic myelomonocytic leukemia","volume":"134","author":"Gurney","year":"2023","journal-title":"Leuk Res"},{"issue":"8","key":"10.1016\/j.bneo.2026.100286_bib29","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1038\/s41375-025-02648-w","article-title":"Multiple TET2 mutations confer additional survival benefit in both myelodysplastic and myeloproliferative chronic myelomonocytic leukemia subtypes","volume":"39","author":"Csizmar","year":"2025","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.bneo.2026.100286_bib30","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/s41408-026-01500-3","article-title":"One vs. 2 vs. \u22653 TET2 mutations in chronic myelomonocytic leukemia: co-mutation patterns and prognostic relevance in the context of contemporary prognostic models including BLAST-mol and CPSS-mol","volume":"16","author":"Yousuf","year":"2026","journal-title":"Blood Cancer J"}],"container-title":["Blood Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S295032802600097X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S295032802600097X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T15:30:50Z","timestamp":1791905450000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S295032802600097X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S295032802600097X"],"URL":"https:\/\/doi.org\/10.1016\/j.bneo.2026.100286","relation":{},"ISSN":["2950-3280"],"issn-type":[{"value":"2950-3280","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic implications of TET2 variant allele frequency in chronic myelomonocytic leukemia: a multicenter study","name":"articletitle","label":"Article Title"},{"value":"Blood Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bneo.2026.100286","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society of Hematology. Published by Elsevier Inc. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100286"}}